Jessica X. Chong, Rebecca Ouwenga, Rebecca L. Anderson, Darrel J

Slides:



Advertisements
Similar presentations
Previous Estimates of Mitochondrial DNA Mutation Level Variance Did Not Account for Sampling Error: Comparing the mtDNA Genetic Bottleneck in Mice and.
Advertisements

Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.
Gene Preference in Maple Syrup Urine Disease Mary M. Nellis, Dean J. Danner The American Journal of Human Genetics Volume 68, Issue 1, Pages (January.
Alternative Splicing QTLs in European and African Populations Halit Ongen, Emmanouil T. Dermitzakis The American Journal of Human Genetics Volume 97, Issue.
Fragile X and X-Linked Intellectual Disability: Four Decades of Discovery Herbert A. Lubs, Roger E. Stevenson, Charles E. Schwartz The American Journal.
Public Opinion about the Importance of Privacy in Biobank Research
Validation and Comparison of Pharmacogenetics-Based Warfarin Dosing Algorithms for Application of Pharmacogenetic Testing  Nitin Roper, Barry Storer,
Use of Homozygosity Mapping to Identify a Region on Chromosome 1 Bearing a Defective Gene That Causes Autosomal Recessive Homozygous Hypercholesterolemia.
Pathogenic Variants for Mendelian and Complex Traits in Exomes of 6,517 European and African Americans: Implications for the Return of Incidental Results 
Population Genetic Structure of the People of Qatar
Common Variants of Large Effect in F12, KNG1, and HRG Are Associated with Activated Partial Thromboplastin Time  Lorna M. Houlihan, Gail Davies, Albert.
Model-free Estimation of Recent Genetic Relatedness
Daniel Greene, Sylvia Richardson, Ernest Turro 
Reliable Identification of Genomic Variants from RNA-Seq Data
Comparing Algorithms for Genotype Imputation
Huwenbo Shi, Nicholas Mancuso, Sarah Spendlove, Bogdan Pasaniuc 
Haplotype Estimation Using Sequencing Reads
Use of Closely Related Affected Individuals for the Genetic Study of Complex Diseases in Founder Populations  C. Bourgain, E. Génin, P. Holopainen, K.
Tuuli Lappalainen, Stephen B. Montgomery, Alexandra C
Accuracy of Haplotype Frequency Estimation for Biallelic Loci, via the Expectation- Maximization Algorithm for Unphased Diploid Genotype Data  Daniele.
Alternative Splicing QTLs in European and African Populations
Leslie S. Emery, Joseph Felsenstein, Joshua M. Akey 
Biased Gene Conversion Skews Allele Frequencies in Human Populations, Increasing the Disease Burden of Recessive Alleles  Joseph Lachance, Sarah A. Tishkoff 
Arpita Ghosh, Fei Zou, Fred A. Wright 
Relationship between Deleterious Variation, Genomic Autozygosity, and Disease Risk: Insights from The 1000 Genomes Project  Trevor J. Pemberton, Zachary.
John Wakeley, Rasmus Nielsen, Shau Neen Liu-Cordero, Kristin Ardlie 
Does the dermatology standardized letter of recommendation alter applicants' chances of matching into residency?  Rebecca F. Wang, BA, Myron Zhang, MD,
Highly Significant Linkage to the SLI1 Locus in an Expanded Sample of Individuals Affected by Specific Language Impairment    The American Journal of.
XMCPDT Does Have Correct Type I Error Rates
Variant Association Tools for Quality Control and Analysis of Large-Scale Sequence and Genotyping Array Data  Gao T. Wang, Bo Peng, Suzanne M. Leal  The.
Genotype/Phenotype Analysis of a Photoreceptor-Specific ATP-Binding Cassette Transporter Gene, ABCR, in Stargardt Disease  Richard Alan Lewis, Noah F.
SNP Arrays in Heterogeneous Tissue: Highly Accurate Collection of Both Germline and Somatic Genetic Information from Unpaired Single Tumor Samples  Guillaume.
Xiangqing Sun, Robert Elston, Nathan Morris, Xiaofeng Zhu 
Selection and Reduced Population Size Cannot Explain Higher Amounts of Neandertal Ancestry in East Asian than in European Human Populations  Bernard Y.
Characteristics of Neutral and Deleterious Protein-Coding Variation among Individuals and Populations  Wenqing Fu, Rachel M. Gittelman, Michael J. Bamshad,
Studying Gene and Gene-Environment Effects of Uncommon and Common Variants on Continuous Traits: A Marker-Set Approach Using Gene-Trait Similarity Regression 
Mamoru Kato, Yusuke Nakamura, Tatsuhiko Tsunoda 
Simultaneous Genotype Calling and Haplotype Phasing Improves Genotype Accuracy and Reduces False-Positive Associations for Genome-wide Association Studies 
Christoph Lange, Nan M. Laird  The American Journal of Human Genetics 
The Population Reference Sample, POPRES: A Resource for Population, Disease, and Pharmacological Genetics Research  Matthew R. Nelson, Katarzyna Bryc,
Hugues Aschard, Bjarni J. Vilhjálmsson, Amit D. Joshi, Alkes L
Shusuke Numata, Tianzhang Ye, Thomas M
Rare-Variant Association Testing for Sequencing Data with the Sequence Kernel Association Test  Michael C. Wu, Seunggeun Lee, Tianxi Cai, Yun Li, Michael.
Lisa Edelmann, Jianli Dong, Robert J. Desnick, Ruth Kornreich 
Erratum The American Journal of Human Genetics
William F. Forrest, Eleanor Feingold 
Naisha Shah, Ying-Chen Claire Hou, Hung-Chun Yu, Rachana Sainger, C
Meiotic Microdeletion Breakpoints in the BRCA1 Gene Are Significantly Associated with Symmetric DNA-Sequence Elements  Beatrice Schmucker, Michael Krawczak 
Wei Pan, Il-Youp Kwak, Peng Wei  The American Journal of Human Genetics 
Jared R. Kohler, David J. Cutler 
Gabriella Esposito, Giuseppe Rescigno, Francesco Salvatore 
L-GATOR: Genetic Association Testing for a Longitudinally Measured Quantitative Trait in Samples with Related Individuals  Xiaowei Wu, Mary Sara McPeek 
Trevor J. Pemberton, Chaolong Wang, Jun Z. Li, Noah A. Rosenberg 
Comparative Superiority of ACE Inhibitors Over Angiotensin Receptor Blockers for People With CKD: Does It Matter?  Dimitris Mavridis, PhD  American Journal.
Classification of Human Chromosome 21 Gene-Expression Variations in Down Syndrome: Impact on Disease Phenotypes  E. Aït Yahya-Graison, J. Aubert, L. Dauphinot,
Nathan D. Montgomery, Sara R. Selitsky, Nirali M. Patel, D
Leslie S. Emery, Kevin M. Magnaye, Abigail W. Bigham, Joshua M
Ellen Pfendner, Jouni Uitto  Journal of Investigative Dermatology 
Ataxia-Telangiectasia: Identification and Detection of Founder-Effect Mutations in the ATM Gene in Ethnic Populations  Milhan Telatar, Sharon Teraoka,
Jung-Ying Tzeng, Chih-Hao Wang, Jau-Tsuen Kao, Chuhsing Kate Hsiao 
Giovanni Parmigiani, Donald A. Berry, Omar Aguilar 
Tao Wang, Robert C. Elston  The American Journal of Human Genetics 
Iuliana Ionita-Laza, Seunggeun Lee, Vlad Makarov, Joseph D
Common Variants of Large Effect in F12, KNG1, and HRG Are Associated with Activated Partial Thromboplastin Time  Lorna M. Houlihan, Gail Davies, Albert.
Alice S. Whittemore, Jerry Halpern 
Messages through Bottlenecks: On the Combined Use of Slow and Fast Evolving Polymorphic Markers on the Human Y Chromosome  Peter de Knijff  The American.
Population Genetic Structure of the People of Qatar
Genetic Analysis of 103 Candidate Genes for Coronary Artery Disease and Associated Phenotypes in a Founder Population Reveals a New Association between.
Passorn Wonnapinij, Patrick F. Chinnery, David C. Samuels 
The Size Distribution of Homozygous Segments in the Human Genome
Presentation transcript:

A Population-Based Study of Autosomal-Recessive Disease-Causing Mutations in a Founder Population  Jessica X. Chong, Rebecca Ouwenga, Rebecca L. Anderson, Darrel J. Waggoner, Carole Ober  The American Journal of Human Genetics  Volume 91, Issue 4, Pages 608-620 (October 2012) DOI: 10.1016/j.ajhg.2012.08.007 Copyright © 2012 The American Society of Human Genetics Terms and Conditions

Figure 1 Results of Gene-Dropping Simulations (A–C) Simulated carrier frequency in the current population for each unique founder mutation. Box plots show the distribution (first quartile, median, and third quartile; dashed lines show minimum and maximum) of frequencies that each founder mutation reached in 100,000 trials under two models. The box plots are ordered in pairs from left to right by the number of descendants (shown along x axis beneath box plots) in the study sample from each founder. The first box plot in each pair shows the simulated frequencies under a neutral model, and the second box plot shows the simulated frequencies under a zero fitness (lethal) model. In the current population, the expected percentage of variants that are attributable to a given founder is shown above the box plots. In (B) and (C), each line represents the simulated frequency of (B) heterozygous carriers and (C) homozygotes for a neutral founder mutation in 25 year birth cohorts. For many founder mutations, the frequency of homozygotes increases over time, whereas there is no such pattern observed for the frequency of carriers. (D) Inbreeding coefficient by birth cohorts. The increase in consanguinity corresponds to the increase in the frequency of homozygotes in (C). The American Journal of Human Genetics 2012 91, 608-620DOI: (10.1016/j.ajhg.2012.08.007) Copyright © 2012 The American Society of Human Genetics Terms and Conditions

Figure 2 Observed Frequencies of Carriers, Carrier Couples, and Homozygotes over Time for 14 Disease Mutations Four CF carrier couples were excluded because they were previously ascertained for having children with CF.24 (A) Heterozygote frequencies in 25 year birth cohorts. The cohorts born before 1925 and after 2000 were excluded because of small sample sizes (n < 60). The black dashed line shows the cumulative carrier frequency for all 14 mutations. (B) Frequency of carrier couples. Both partners of one couple were carriers of DNAJC19 IVS3-1G>C and TECR p.Pro182Leu and are included twice in this figure. (C) Frequency of homozygotes born to each couple in (B). There are no homozygotes shown among the children of the ≥2000 marriage cohort because our study included children who were 6 years of age or older at the time of our last study in 2006–2009. Although we are aware that these families include children homozygous for SMA (n = 4) and CF (n = 2), we did not include them because we do not know the status of children born to all carrier couples. In addition, because infants homozygous for ZMPSTE24 c.1085dupT, causing RD, die within a few days of birth, homozygotes for this mutation would not have been included in our studies. However, family-history interviews with carrier couples and acquisition of medical records allowed us to identify homozygous children, who are included in this figure. The American Journal of Human Genetics 2012 91, 608-620DOI: (10.1016/j.ajhg.2012.08.007) Copyright © 2012 The American Society of Human Genetics Terms and Conditions

Figure 3 Distribution of Carrier Burden in 686 Subjects Who Were Genotyped for All 14 Mutations in This Study The mean carrier burden (defined as the number of mutations per individual) is 1.096 mutations. Black dots represent the theoretical expected number of subjects in each bin of mutations with a Poisson distribution with λ = 1.096. The American Journal of Human Genetics 2012 91, 608-620DOI: (10.1016/j.ajhg.2012.08.007) Copyright © 2012 The American Society of Human Genetics Terms and Conditions